Your Global Leader in Stem Cell Market Research
As you start to learn about stem cells, one of the most common questions to have is, “What types of stem cells exist?” There is not an agreed-upon number of stem cell types, because one can classify stem cells either by differentiation potential (what they can turn into) or by origin (from where they are sourced).
This post is dedicated to explaining the five types of stem cells, based on differentiation potential. [Read more…]
Are you wondering about the term neural stem cell versus neuronal stem cell, but don’t yet know the difference? If so, you’re not alone. The short answer is that neural means pertaining to a nerve or nerves (the cordlike bundles of fibers made up of neurons), while neuronal means pertaining to neurons (the conducting cells of the nervous system).
With this understanding, the term neural stem cell describes multipotent stem cells that can self-renew and differentiate into specialized cells of the brain, such as neurons, astrocytes, or oligodendrocytes.
In contrast, neuronal is a term that describes neurons, so practically speaking, it is often used in the context of describing neuronal networks (networks of neurons) or describing neuronal differentiation. For example, one might talk about stem cell-derived neuronal networks or neuronal differentiation of induced pluripotent stem cells (iPS cells).
Therefore, when it comes to the world of stem cells, the cells that are capable of differentiating into specialized cells of the brain are neural stem cells.
With this surface level understanding, let’s dive deeper.
What do we know of the safety and efficacy of stem cell therapeutics? Over 50 years have passed since the discovery of hematopoietic stem cells (bone marrow transplantation to cure diseases such as leukemia), over 20 years since the discovery of human embryonic stem cells (hESC), and 15 years since the discovery of induced pluripotent stem cells (iPS cells). There are now thousands of stem cell trials underway in clinics worldwide.
Despite this experience, what do we actually know about the safety and efficacy of stem cell therapeutics? [Read more…]
Treatment for multiple sclerosis (MS) is an evolving area and one in which new therapeutic approaches are rapidly advancing. Led by Dr. Saud Sadiq, the Tisch MS Research Center of New York is pursuing a Phase II clinical trial exploring the use of stem cell technology for the treatment for MS. The announcement followed positive results from an FDA-approved Phase I stem cell trial for MS. [Read more…]
“Stem Cell Research Products – Opportunities, Tools, & Technologies” is a global strategic report that evaluates opportunities across the entire stem cell product spectrum with an emphasis on opportunities for research product development.
This report explores market opportunities by stem cell type, including MSCs, hematopoietic stem cells, induced pluripotent stem cells, embryonic stem cells, neural stem cells, and other stem cell types.
In this article:
